1. Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes 
Stuart A. Ross, MB CHB, FRACP, FRCP(C) 
The American Journal of Medicine 
Volume 126, Issue 9, Pages S38-S48 (September 2013)
DOI: /j.amjmed
Copyright © 2013 Elsevier Inc. Terms and Conditions

2. Figure 1 Factors influencing treatment success
(adapted from Allen et al, ).
The American Journal of Medicine  , S38-S48DOI: ( /j.amjmed )
Copyright © 2013 Elsevier Inc. Terms and Conditions

3. Figure 2
Weighted mean weight change (95% confidence interval) observed with various noninsulin type 2 diabetes therapies (data from Phung et al, ). αGIs = alpha-glucosidase inhibitors; DPP-4is = dipeptidyl peptidase-4 inhibitors; GLP-1RA = glucagon-like peptide-1 receptor agonist; SU = sulfonylurea; TZD = thiazolidinedione.
The American Journal of Medicine  , S38-S48DOI: ( /j.amjmed )
Copyright © 2013 Elsevier Inc. Terms and Conditions